Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4786 to 4800 of 8314 results

  1. 1.1 Evidence on the safety of electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease shows no major safety concerns. For people who are having an acute exacerbation of their chronic condition and are unable to exercise, evidence of efficacy is adequate to support the use of this procedure provided that standard arrangements are in place for clinical governance, consent and audit.   Find out  what standard arrangements mean on the NICE website . For people who are able to exercise, evidence on efficacy is inadequate in quality. Therefore, this procedure should only be used in the context of research. Find out  what only in research means on the NICE website .

    Recommendation ID IPG677 Question 1.1 Evidence on the safety of electrical stimulation to improve muscle strength in chronic respiratory

    Research recommendation
    Published
    10 August 2020

  2. Electronic Decision Support:- What is the clinical and cost effectiveness of an electronic decision support system compared with current practice in reducing inappropriate blood transfusions, overall rates of blood transfusion and mortality?

    Recommendation ID NG24/2 Question Electronic Decision Support:- What is the clinical and cost effectiveness of an electronic decision support

    Research recommendation
    Published
    11 December 2015

  3. Managing anaemia: For adults, children and young people with CKD and anaemia, what is the diagnostic accuracy of eGFR thresholds of 60, 45, and 30 ml/min/1.73 m2 for determining whether the anaemia is due to CKD?

    Recommendation ID NG203/13 Question Managing anaemia: For adults, children and young people with CKD and anaemia, what is the diagnostic

    Research recommendation
    Published
    30 September 2021

  4. Managing anaemia: For adults, children and young people with CKD and anaemia who are on peritoneal dialysis, what amount of intravenous (IV) iron is most clinically and cost effective in managing anaemia and its associated outcomes (including quality of life)?

    Recommendation ID NG203/14 Question Managing anaemia: For adults, children and young people with CKD and anaemia who are on peritoneal

    Research recommendation
    Published
    30 September 2021

  5. For adults who want to stop smoking, what is the effectiveness and cost effectiveness of Allen Carr's Easyway programme delivered in formats other than in-person group seminars (for example online or using the self-help book) compared with other methods of smoking cessation?

    Recommendation ID NG209/14 Question For adults who want to stop smoking, what is the effectiveness and cost effectiveness of Allen Carr's

    Research recommendation
    Published
    7 September 2022

  6. Endoscopic treatments: For adults with Barrett's oesophagus with dysplasia, what is the effectiveness of different endoscopic ablation techniques alone or in combination with endoscopic resection?

    Recommendation ID NG231/04A Question Endoscopic treatments: For adults with Barrett's oesophagus with dysplasia, what is the effectiveness

    Research recommendation
    Published
    9 March 2023

  7. Endoscopic treatments: For adults with stage 1 oesophageal adenocarcinoma, what is the effectiveness of different endoscopic ablation techniques alone or in combination with endoscopic resection?

    Recommendation ID NG231/04B Question Endoscopic treatments: For adults with stage 1 oesophageal adenocarcinoma, what is the effectiveness

    Research recommendation
    Published
    9 March 2023

  8. Increasing the dose of ICS within a personalised self-management programme for children and young people - For children and young people with asthma that is managed in primary care, is there an advantage to increasing the inhaled corticosteroid (ICS) dose when asthma control has deteriorated compared with using the usual dose in a self-management programme?

    Recommendation ID NG80/11 Question Increasing the dose of ICS within a personalised self-management programme for children and young people

    Research recommendation
    Published
    6 August 2021

  9. Renin–angiotensin–aldosterone system antagonists: For people aged over 75 years with CKD, what is the clinical effectiveness of renin–angiotensin–aldosterone system (RAAS) antagonists? [2014]

    Recommendation ID NG203/20 Question Renin–angiotensin–aldosterone system antagonists: For people aged over 75 years with CKD, what is the

    Research recommendation
    Published
    30 September 2021

  10. Multicomponent intervention: For people in long-term care, is a multicomponent non-pharmacological intervention more clinically and cost effective than usual care in preventing the development of delirium?

    Recommendation ID CG103/04 Question Multicomponent intervention: For people in long-term care, is a multicomponent non-pharmacological

    Research recommendation
    Published
    3 February 2023

  11. Starting asthma treatment:- In adults, young people and children with asthma who have not been treated previously, is it more clinically and cost effective to start treatment with a reliever alone (a short-acting beta2 agonist [SABA]) or with a reliever (a SABA) and maintenance therapy (such as ICS)? Are there specificprognostic features that indicate that one of these treatment options may be more appropriate for some groups?

    Recommendation ID NG80/6 Question Starting asthma treatment:- In adults, young people and children with asthma who have not been treated

    Research recommendation
    Published
    18 October 2018

  12. Social media:- How effective are online social media and networks at improving health and wellbeing and reducing health inequalities when they are used:- as a method of community engagement?- to support an existing community engagement approach?

    Recommendation ID NG44/4 Question Social media:- How effective are online social media and networks at improving health and wellbeing and

    Research recommendation
    Published
    7 April 2016

  13. What is the effectivness of statin treatment in older people?

    Recommendation ID NG238//2 Question What is the effectivness of statin treatment in older people? Any explanatory notes(if applicable)

    Research recommendation
    Published
    3 May 2024

  14. The committee noted that there was no clinical evidence showing that having sodium zirconium cyclosilicate improved length or quality of life or allowed patients to stay on optimal doses of renin-angiotensin-aldosterone system (RAAS) inhibitors. It therefore considered that it would be valuable to have studies comparing sodium zirconium cyclosilicate plus standard care with standard care alone in people with confirmed hyperkalaemia of 6.0 mmol/litre and above, and that these should investigate: mortality disease progression patterns of RAAS inhibitor use healthcare utilisation, and health-related quality of life.

    Recommendation ID TA599/1 Question The committee noted that there was no clinical evidence showing that having sodium zirconium cyclosilicate

    Research recommendation
    Published
    8 November 2019

  15. What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD spray for children, young people and adults with spasticity? In particular, what is the impact of spasticity on improvements in quality of life?

    Recommendation ID NG144/5 Question What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD

    Research recommendation
    Published
    10 February 2020